E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/27/2005 in the Prospect News PIPE Daily.

New Issue: HealthRenu releases details on $10 million equity line

By Sheri Kasprzak

Atlanta, May 27 - HealthRenu Medical Inc. revealed the details of its previously announced $10 million standby equity distribution agreement in a form 8-K filed with the Securities and Exchange Commission.

Under the terms of the agreement, Cornell Capital Partners LP may buy shares from HealthRenu at 97% of the lowest volume weighted average price five trading days after notice of a draw.

The length of the agreement is the earlier of two years or once the company has received $10 million.

There is a $350,000 per week limit on each advance.

Cornell will retain 5% of each draw under the agreement.

Monitor Capital Inc. was the placement agent.

Based in Houston, HealthRenu is a healthcare company focused on skin and wound-care products.

Issuer:HealthRenu Medical Inc.
Issue:Standby equity distribution agreement
Amount:$10 million
Price:97% of the lowest volume weighted average price five trading days after notice
Tenor:Two years
Warrants:No
Investors:Cornell Capital Partners LP
Placement agent:Monitor Capital Inc.
Settlement date:May 23
Stock price:$0.19 at close May 23

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.